Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca M. Marin, Jann N. Sarkaria, Jason E. Conage‐Pough et al.|Neuro-Oncology|2021Cited by 81